Elastrin Therapeutics named winner of 2021 InnoVision Award for Technology Development

Elastrin Therapeutics of Simpsonville, SC has been named winner of the 2021 InnoVision Award for Technology Development, organizers have announced.

Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries and tissue by targeting the elastic fiber that makes them work.

Founded by Mr.Douglas Mulhall, Dr.Naren Vyavahare, Dr.Charles D. Rice, and Dr. Mirko Stange, the SCRA Client Company has demonstrated proof-of-concept for a patented therapeutic compound that may provide needed repair and restorative function to lungs that have been damaged by the COVID-19 virus. According to Vyavahare, “Elastin is present in lung alveoli that are being degraded by enzymes such as neutrophil elastases and MMPs released by inflammatory cells in COVID-19 infection of lungs. Our elastin targeting nanoparticle can also target drugs to the lungs and prevent lung injury.

Click here to view the winner’s video.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

February 21-23, 2023 Charleston, SCSCbio 2023 Annual Conference